Announce Date | 04/25/2024 |
EPS Normalized Actual | $-0.35377 (Beat by $0.28623) |
EPS GAAP Actual | $-0.35377 (Beat by $0.28623) |
Revenue Actual | $0.733699B |
Revenue Surprise | Beat by $733.699M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 1.43 | 42.97 | 1.30089 | 1.4851 | 6 |
Dec 2025 | -1.45719 | -42.16 | -3.6 | 1.36 | 18 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2022 (Mar 2022) | -0.2 | -0.2 | 0.733699B | 21.74% | 733.7M |
FQ4 2021 (Dec 2021) | 0.18 | 0.18 | 0.865329B | 24.9% | 865.33M |
FQ3 2021 (Sep 2021) | 0.52 | 0.52 | 0.679953B | 33.57% | 679.95M |
FQ2 2021 (Jun 2021) | 0.55 | 0.55 | 0.645119B | 44.81% | 645.12M |
FQ1 2021 (Mar 2021) | 0.59 | 0.59 | 0.574183B | 44.14% | 574.18M |
FQ4 2020 (Dec 2020) | 0.53 | 0.53 | 0.649886B | 36.72% | 649.89M |
FQ3 2020 (Sep 2020) | 0.1 | 0.1 | 0.451663B | 42.23% | 451.66M |
FQ2 2020 (Jun 2020) | -0.35 | -0.35 | 0.356073B | 29.76% | 356.07M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | -0.1315 | -- | -0.13614 | -0.12797 | 7 |
FQ3 2027 (Jul 2027) | -0.0918 | -- | -0.09504033 | -0.08933482 | 6 |
FQ2 2027 (Jun 2027) | -0.1114 | -- | -0.11616 | -0.10838 | 6 |
FQ1 2027 (Mar 2027) | -0.4337 | -- | -0.45223 | -0.42196 | 6 |
FQ4 2026 (Oct 2026) | -0.13688 | -- | -0.14171 | -0.1332 | 6 |
FQ3 2026 (Jul 2026) | -0.14271 | -- | -0.14775 | -0.13888 | 11 |
FQ2 2026 (Jun 2026) | -0.16261 | -- | -0.16956 | -0.15821 | 9 |
FQ1 2026 (Mar 2026) | -0.26029 | -- | -0.27141 | -0.25325 | 9 |
FQ4 2025 (Oct 2025) | -0.24432 | -- | -0.25294 | -0.23776 | 7 |
FQ3 2025 (Jul 2025) | -0.24544 | -- | -0.2541 | -0.23885 | 8 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 1.31B | -- | 1.28B | 1.34B | 8 |
FQ3 2027 (Jul 2027) | 1.22B | -- | 1.19B | 1.25B | 8 |
FQ2 2027 (Jun 2027) | 1.14B | -- | 1.12B | 1.18B | 8 |
FQ1 2027 (Mar 2027) | 1.05B | -- | 1.03B | 1.09B | 8 |
FQ4 2026 (Oct 2026) | 1.28B | -- | 1.25B | 1.31B | 8 |
FQ3 2026 (Jul 2026) | 1.19B | -- | 1.16B | 1.22B | 8 |
FQ2 2026 (Jun 2026) | 1.18B | -- | 1.16B | 1.22B | 13 |
FQ1 2026 (Mar 2026) | 1.08B | -- | 1.06B | 1.12B | 8 |
FQ4 2025 (Oct 2025) | 1.14B | -- | 1.12B | 1.18B | 7 |
FQ3 2025 (Jul 2025) | 1.05B | -- | 1.03B | 1.08B | 7 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2022 (Mar 2022) | -0.2 | -0.2 | 100% | |
FQ4 2021 (Dec 2021) | 0.18 | 0.18 | 100% | |
FQ3 2021 (Sep 2021) | 0.52 | 0.52 | 100% | |
FQ2 2021 (Jun 2021) | 0.55 | 0.55 | 100% | |
FQ1 2021 (Mar 2021) | 0.59 | 0.59 | 100% | |
FQ4 2020 (Dec 2020) | 0.53 | 0.53 | 100% | |
FQ3 2020 (Sep 2020) | 0.1 | 0.1 | 100% | |
FQ2 2020 (Jun 2020) | -0.35 | -0.35 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2022 (Mar 2022) | $0B | $0.73B | $733.7M | 100% |
FQ4 2021 (Dec 2021) | $0B | $0.87B | $865.33M | 100% |
FQ3 2021 (Sep 2021) | $0B | $0.68B | $679.95M | 100% |
FQ2 2021 (Jun 2021) | $0B | $0.65B | $645.12M | 100% |
FQ1 2021 (Mar 2021) | $0B | $0.57B | $574.18M | 100% |
FQ4 2020 (Dec 2020) | $0B | $0.65B | $649.89M | 100% |
FQ3 2020 (Sep 2020) | $0B | $0.45B | $451.66M | 100% |
FQ2 2020 (Jun 2020) | $0B | $0.36B | $356.07M | 100% |